• Who we are

κλ body discovery, a simple process

We first identify antibodies using our common heavy chain antibody libraries. Then, we simply co-express one heavy chain and the two light chains. The bispecific κλ bodies can be directly tested using the cell culture supernatant or easily purified using standard affinity chromatography.

This process ensures a unique level of bsAb purity and integrity

High throughput bsAb screening

Fixed VH Diversified VLs

  • This process ensures a unique level of bsAb purity and integrity

  • High throughput bsAb screening

  • Fixed VH Diversified VLs

Back

κλ bodies, truly human

Native, non-engineered, human bispecific antibodies maintain human antibody sequence and structure.

A κλ body consists of:

  • 2 identical heavy chains
  • 2 different light chains: one kappa (κ) and one lambda (λ)

kl bodies truly human 1

First patient dosed with NILK-2301 in Phase I clinical trial

First-in-human trial of a CEACAM5xCD3 bispecific κλ body for solid cancer


Read more

LinkedIn